Rennova Health, Inc.
Rennova Health, Inc. RNVA Peers
See (RNVA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RNVA | $0.00 | +0.00% | 43051.00 | N/A | $0.05 | N/A |
| LZAGY | $69.09 | +0.54% | 49.84B | 65.18 | $1.06 | +0.19% |
| LZAGF | $674.95 | -2.11% | 47.46B | 63.32 | $10.66 | +0.71% |
| WUXAY | $8.15 | +3.11% | 25.19B | 15.09 | $0.54 | +0.71% |
| WUXIF | $7.34 | N/A | 21.49B | 13.59 | $0.54 | +0.52% |
| BMXMF | $129.73 | +0.00% | 15.30B | 31.88 | $4.07 | +0.71% |
| ERFSF | $61.89 | -5.24% | 10.89B | 26.68 | $2.32 | +1.76% |
| SKHHY | $16.04 | -0.12% | 7.70B | 22.59 | $0.71 | +3.91% |
| SKHCF | $14.80 | N/A | 7.11B | 20.56 | $0.72 | +3.92% |
| DSRLF | $104.69 | +0.00% | 5.64B | 26.98 | $3.88 | +2.12% |
Stock Comparison
RNVA vs LZAGY Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, LZAGY has a market cap of 49.84B. Regarding current trading prices, RNVA is priced at $0.00, while LZAGY trades at $69.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas LZAGY's P/E ratio is 65.18. In terms of profitability, RNVA's ROE is +0.23%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, RNVA is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs LZAGF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, LZAGF has a market cap of 47.46B. Regarding current trading prices, RNVA is priced at $0.00, while LZAGF trades at $674.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas LZAGF's P/E ratio is 63.32. In terms of profitability, RNVA's ROE is +0.23%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, RNVA is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs WUXAY Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, WUXAY has a market cap of 25.19B. Regarding current trading prices, RNVA is priced at $0.00, while WUXAY trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas WUXAY's P/E ratio is 15.09. In terms of profitability, RNVA's ROE is +0.23%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, RNVA and WUXAY have similar daily volatility (0.00).
RNVA vs WUXIF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, WUXIF has a market cap of 21.49B. Regarding current trading prices, RNVA is priced at $0.00, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, RNVA's ROE is +0.23%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, RNVA and WUXIF have similar daily volatility (0.00).
RNVA vs BMXMF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, BMXMF has a market cap of 15.30B. Regarding current trading prices, RNVA is priced at $0.00, while BMXMF trades at $129.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas BMXMF's P/E ratio is 31.88. In terms of profitability, RNVA's ROE is +0.23%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, RNVA is less volatile compared to BMXMF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs ERFSF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ERFSF has a market cap of 10.89B. Regarding current trading prices, RNVA is priced at $0.00, while ERFSF trades at $61.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ERFSF's P/E ratio is 26.68. In terms of profitability, RNVA's ROE is +0.23%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, RNVA is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs SKHHY Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, SKHHY has a market cap of 7.70B. Regarding current trading prices, RNVA is priced at $0.00, while SKHHY trades at $16.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas SKHHY's P/E ratio is 22.59. In terms of profitability, RNVA's ROE is +0.23%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, RNVA is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs SKHCF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, SKHCF has a market cap of 7.11B. Regarding current trading prices, RNVA is priced at $0.00, while SKHCF trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas SKHCF's P/E ratio is 20.56. In terms of profitability, RNVA's ROE is +0.23%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, RNVA is less volatile compared to SKHCF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs DSRLF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, DSRLF has a market cap of 5.64B. Regarding current trading prices, RNVA is priced at $0.00, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas DSRLF's P/E ratio is 26.98. In terms of profitability, RNVA's ROE is +0.23%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, RNVA is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs HNGZY Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, HNGZY has a market cap of 4.49B. Regarding current trading prices, RNVA is priced at $0.00, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, RNVA's ROE is +0.23%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, RNVA is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs VIMGF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, VIMGF has a market cap of 1.81B. Regarding current trading prices, RNVA is priced at $0.00, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas VIMGF's P/E ratio is 87.50. In terms of profitability, RNVA's ROE is +0.23%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, RNVA and VIMGF have similar daily volatility (0.00).
RNVA vs MRCHF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, MRCHF has a market cap of 1.24B. Regarding current trading prices, RNVA is priced at $0.00, while MRCHF trades at $21.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas MRCHF's P/E ratio is 66.06. In terms of profitability, RNVA's ROE is +0.23%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, RNVA is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs IDGXF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IDGXF has a market cap of 186.02M. Regarding current trading prices, RNVA is priced at $0.00, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, RNVA's ROE is +0.23%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, RNVA is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs EDTXF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, EDTXF has a market cap of 183.96M. Regarding current trading prices, RNVA is priced at $0.00, while EDTXF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas EDTXF's P/E ratio is -10.75. In terms of profitability, RNVA's ROE is +0.23%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, RNVA is less volatile compared to EDTXF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs AMCY Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, AMCY has a market cap of 171.27M. Regarding current trading prices, RNVA is priced at $0.00, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas AMCY's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to AMCY's ROE of N/A. Regarding short-term risk, RNVA and AMCY have similar daily volatility (0.00).
RNVA vs NNGRF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, NNGRF has a market cap of 164.30M. Regarding current trading prices, RNVA is priced at $0.00, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, RNVA's ROE is +0.23%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, RNVA and NNGRF have similar daily volatility (0.00).
RNVA vs ATLN Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ATLN has a market cap of 154.70M. Regarding current trading prices, RNVA is priced at $0.00, while ATLN trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ATLN's P/E ratio is -0.72. In terms of profitability, RNVA's ROE is +0.23%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, RNVA is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs CORBF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, CORBF has a market cap of 140.61M. Regarding current trading prices, RNVA is priced at $0.00, while CORBF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas CORBF's P/E ratio is 3.00. In terms of profitability, RNVA's ROE is +0.23%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, RNVA and CORBF have similar daily volatility (0.00).
RNVA vs THOXF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, THOXF has a market cap of 130.94M. Regarding current trading prices, RNVA is priced at $0.00, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas THOXF's P/E ratio is -14.40. In terms of profitability, RNVA's ROE is +0.23%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, RNVA is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs DIUXF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, DIUXF has a market cap of 115.49M. Regarding current trading prices, RNVA is priced at $0.00, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, RNVA's ROE is +0.23%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, RNVA and DIUXF have similar daily volatility (0.00).
RNVA vs ANPCF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ANPCF has a market cap of 99.98M. Regarding current trading prices, RNVA is priced at $0.00, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, RNVA's ROE is +0.23%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, RNVA is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs TIHE Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, TIHE has a market cap of 71.85M. Regarding current trading prices, RNVA is priced at $0.00, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas TIHE's P/E ratio is 0.32. In terms of profitability, RNVA's ROE is +0.23%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, RNVA and TIHE have similar daily volatility (0.00).
RNVA vs BIOGF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, BIOGF has a market cap of 65.41M. Regarding current trading prices, RNVA is priced at $0.00, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, RNVA's ROE is +0.23%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, RNVA and BIOGF have similar daily volatility (0.00).
RNVA vs PFGTF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, PFGTF has a market cap of 64.95M. Regarding current trading prices, RNVA is priced at $0.00, while PFGTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas PFGTF's P/E ratio is -4.00. In terms of profitability, RNVA's ROE is +0.23%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, RNVA is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs PCNEF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, PCNEF has a market cap of 61.99M. Regarding current trading prices, RNVA is priced at $0.00, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, RNVA's ROE is +0.23%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, RNVA and PCNEF have similar daily volatility (0.00).
RNVA vs LDXHF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, LDXHF has a market cap of 43.26M. Regarding current trading prices, RNVA is priced at $0.00, while LDXHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas LDXHF's P/E ratio is -5.78. In terms of profitability, RNVA's ROE is +0.23%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, RNVA is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs BIOQ Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, BIOQ has a market cap of 40.22M. Regarding current trading prices, RNVA is priced at $0.00, while BIOQ trades at $45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas BIOQ's P/E ratio is 15.85. In terms of profitability, RNVA's ROE is +0.23%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, RNVA and BIOQ have similar daily volatility (0.00).
RNVA vs CLIFF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, CLIFF has a market cap of 29.65M. Regarding current trading prices, RNVA is priced at $0.00, while CLIFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas CLIFF's P/E ratio is -1.93. In terms of profitability, RNVA's ROE is +0.23%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, RNVA is less volatile compared to CLIFF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs SNANF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, SNANF has a market cap of 27.23M. Regarding current trading prices, RNVA is priced at $0.00, while SNANF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas SNANF's P/E ratio is -12.57. In terms of profitability, RNVA's ROE is +0.23%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, RNVA and SNANF have similar daily volatility (0.00).
RNVA vs ANPCY Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ANPCY has a market cap of 27.08M. Regarding current trading prices, RNVA is priced at $0.00, while ANPCY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ANPCY's P/E ratio is -0.92. In terms of profitability, RNVA's ROE is +0.23%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, RNVA is less volatile compared to ANPCY. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs IMMVF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IMMVF has a market cap of 22.60M. Regarding current trading prices, RNVA is priced at $0.00, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, RNVA's ROE is +0.23%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, RNVA is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs VILGF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, VILGF has a market cap of 20.67M. Regarding current trading prices, RNVA is priced at $0.00, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas VILGF's P/E ratio is -0.30. In terms of profitability, RNVA's ROE is +0.23%, compared to VILGF's ROE of N/A. Regarding short-term risk, RNVA and VILGF have similar daily volatility (0.00).
RNVA vs PCHM Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, PCHM has a market cap of 20.19M. Regarding current trading prices, RNVA is priced at $0.00, while PCHM trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas PCHM's P/E ratio is -0.02. In terms of profitability, RNVA's ROE is +0.23%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, RNVA is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs BMKDF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, BMKDF has a market cap of 17.26M. Regarding current trading prices, RNVA is priced at $0.00, while BMKDF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas BMKDF's P/E ratio is -18.99. In terms of profitability, RNVA's ROE is +0.23%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, RNVA is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs PMSNF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, PMSNF has a market cap of 14.76M. Regarding current trading prices, RNVA is priced at $0.00, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, RNVA's ROE is +0.23%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, RNVA and PMSNF have similar daily volatility (0.00).
RNVA vs ABDXF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ABDXF has a market cap of 13.55M. Regarding current trading prices, RNVA is priced at $0.00, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, RNVA's ROE is +0.23%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, RNVA and ABDXF have similar daily volatility (0.00).
RNVA vs IZOZF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IZOZF has a market cap of 13.46M. Regarding current trading prices, RNVA is priced at $0.00, while IZOZF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IZOZF's P/E ratio is -7.41. In terms of profitability, RNVA's ROE is +0.23%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, RNVA is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs MXDHF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, MXDHF has a market cap of 8.65M. Regarding current trading prices, RNVA is priced at $0.00, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, RNVA's ROE is +0.23%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, RNVA and MXDHF have similar daily volatility (0.00).
RNVA vs VRCDF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, VRCDF has a market cap of 7.28M. Regarding current trading prices, RNVA is priced at $0.00, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, RNVA's ROE is +0.23%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, RNVA is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs TDSGF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, TDSGF has a market cap of 6.49M. Regarding current trading prices, RNVA is priced at $0.00, while TDSGF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas TDSGF's P/E ratio is -2.17. In terms of profitability, RNVA's ROE is +0.23%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, RNVA is less volatile compared to TDSGF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs SQIDF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, SQIDF has a market cap of 6.07M. Regarding current trading prices, RNVA is priced at $0.00, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, RNVA's ROE is +0.23%, compared to SQIDF's ROE of +0.00%. Regarding short-term risk, RNVA is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs GNTLF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, GNTLF has a market cap of 6.05M. Regarding current trading prices, RNVA is priced at $0.00, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, RNVA's ROE is +0.23%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, RNVA and GNTLF have similar daily volatility (0.00).
RNVA vs AVCRF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, AVCRF has a market cap of 4.95M. Regarding current trading prices, RNVA is priced at $0.00, while AVCRF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas AVCRF's P/E ratio is -4.88. In terms of profitability, RNVA's ROE is +0.23%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, RNVA and AVCRF have similar daily volatility (0.00).
RNVA vs SLDX Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, SLDX has a market cap of 4.78M. Regarding current trading prices, RNVA is priced at $0.00, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas SLDX's P/E ratio is -0.01. In terms of profitability, RNVA's ROE is +0.23%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, RNVA is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs JMPHF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, JMPHF has a market cap of 4.14M. Regarding current trading prices, RNVA is priced at $0.00, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, RNVA's ROE is +0.23%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, RNVA is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs IDXG Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IDXG has a market cap of 3.68M. Regarding current trading prices, RNVA is priced at $0.00, while IDXG trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IDXG's P/E ratio is 2.97. In terms of profitability, RNVA's ROE is +0.23%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, RNVA is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs SZLSF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, SZLSF has a market cap of 3.54M. Regarding current trading prices, RNVA is priced at $0.00, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, RNVA's ROE is +0.23%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, RNVA is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs ICBU Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ICBU has a market cap of 3.45M. Regarding current trading prices, RNVA is priced at $0.00, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ICBU's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, RNVA is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs IBXXF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IBXXF has a market cap of 1.61M. Regarding current trading prices, RNVA is priced at $0.00, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, RNVA's ROE is +0.23%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, RNVA is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs IDTA Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IDTA has a market cap of 1.48M. Regarding current trading prices, RNVA is priced at $0.00, while IDTA trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IDTA's P/E ratio is 3.66. In terms of profitability, RNVA's ROE is +0.23%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, RNVA is less volatile compared to IDTA. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs IVRO Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IVRO has a market cap of 1.42M. Regarding current trading prices, RNVA is priced at $0.00, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IVRO's P/E ratio is -0.89. In terms of profitability, RNVA's ROE is +0.23%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, RNVA and IVRO have similar daily volatility (0.00).
RNVA vs DIGP Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, DIGP has a market cap of 1.09M. Regarding current trading prices, RNVA is priced at $0.00, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas DIGP's P/E ratio is -1.04. In terms of profitability, RNVA's ROE is +0.23%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, RNVA is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs SCRSF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, SCRSF has a market cap of 847776.00. Regarding current trading prices, RNVA is priced at $0.00, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, RNVA's ROE is +0.23%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, RNVA and SCRSF have similar daily volatility (0.00).
RNVA vs EPGNF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, EPGNF has a market cap of 692790.00. Regarding current trading prices, RNVA is priced at $0.00, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, RNVA's ROE is +0.23%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, RNVA is less volatile compared to EPGNF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs NSTM Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, NSTM has a market cap of 468815.00. Regarding current trading prices, RNVA is priced at $0.00, while NSTM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas NSTM's P/E ratio is -0.14. In terms of profitability, RNVA's ROE is +0.23%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, RNVA is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs MBGNF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, MBGNF has a market cap of 172578.00. Regarding current trading prices, RNVA is priced at $0.00, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, RNVA's ROE is +0.23%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, RNVA and MBGNF have similar daily volatility (0.00).
RNVA vs NVTAQ Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, NVTAQ has a market cap of 85948.00. Regarding current trading prices, RNVA is priced at $0.00, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, RNVA's ROE is +0.23%, compared to NVTAQ's ROE of +1.79%. Regarding short-term risk, RNVA is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs ARYC Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ARYC has a market cap of 79348.00. Regarding current trading prices, RNVA is priced at $0.00, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ARYC's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, RNVA is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs HCLC Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, HCLC has a market cap of 73985.00. Regarding current trading prices, RNVA is priced at $0.00, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas HCLC's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, RNVA and HCLC have similar daily volatility (0.00).
RNVA vs MEDVF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, MEDVF has a market cap of 54038.00. Regarding current trading prices, RNVA is priced at $0.00, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, RNVA's ROE is +0.23%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, RNVA and MEDVF have similar daily volatility (0.00).
RNVA vs CHHL Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, CHHL has a market cap of 37320.00. Regarding current trading prices, RNVA is priced at $0.00, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas CHHL's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, RNVA is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs IHTI Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, IHTI has a market cap of 32514.00. Regarding current trading prices, RNVA is priced at $0.00, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas IHTI's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, RNVA is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs MEDD Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, MEDD has a market cap of 31910.00. Regarding current trading prices, RNVA is priced at $0.00, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas MEDD's P/E ratio is -0.01. In terms of profitability, RNVA's ROE is +0.23%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, RNVA and MEDD have similar daily volatility (0.00).
RNVA vs CGNH Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, CGNH has a market cap of 24000.00. Regarding current trading prices, RNVA is priced at $0.00, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas CGNH's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, RNVA is less volatile compared to CGNH. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs TOMDF Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, TOMDF has a market cap of 14081.00. Regarding current trading prices, RNVA is priced at $0.00, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas TOMDF's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, RNVA is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs RSHN Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, RSHN has a market cap of 8175.00. Regarding current trading prices, RNVA is priced at $0.00, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas RSHN's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, RNVA and RSHN have similar daily volatility (0.00).
RNVA vs ABMC Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ABMC has a market cap of 4810.00. Regarding current trading prices, RNVA is priced at $0.00, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ABMC's P/E ratio is 0.01. In terms of profitability, RNVA's ROE is +0.23%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, RNVA and ABMC have similar daily volatility (0.00).
RNVA vs RGDXQ Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, RGDXQ has a market cap of 3880.00. Regarding current trading prices, RNVA is priced at $0.00, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, RNVA is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs GWHP Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, GWHP has a market cap of 1313.00. Regarding current trading prices, RNVA is priced at $0.00, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas GWHP's P/E ratio is -0.00. In terms of profitability, RNVA's ROE is +0.23%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, RNVA is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs CYPS Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, CYPS has a market cap of 811.00. Regarding current trading prices, RNVA is priced at $0.00, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas CYPS's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to CYPS's ROE of N/A. Regarding short-term risk, RNVA is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for RNVA.
RNVA vs ROSGQ Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, ROSGQ has a market cap of 593.00. Regarding current trading prices, RNVA is priced at $0.00, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, RNVA and ROSGQ have similar daily volatility (0.00).
RNVA vs BIOCQ Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, BIOCQ has a market cap of 263.00. Regarding current trading prices, RNVA is priced at $0.00, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, RNVA's ROE is +0.23%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, RNVA and BIOCQ have similar daily volatility (0.00).
RNVA vs HTGMQ Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, HTGMQ has a market cap of 221.00. Regarding current trading prices, RNVA is priced at $0.00, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, RNVA and HTGMQ have similar daily volatility (0.00).
RNVA vs DMTKQ Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, DMTKQ has a market cap of 35.00. Regarding current trading prices, RNVA is priced at $0.00, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, RNVA and DMTKQ have similar daily volatility (0.00).
RNVA vs OPGX Comparison
RNVA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNVA stands at 43051.00. In comparison, OPGX has a market cap of 17.00. Regarding current trading prices, RNVA is priced at $0.00, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNVA currently has a P/E ratio of N/A, whereas OPGX's P/E ratio is N/A. In terms of profitability, RNVA's ROE is +0.23%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, RNVA and OPGX have similar daily volatility (0.00).